Earnings Estimate | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 3 | 4 | 3 |
Avg. Estimate | 0.09 | 0.16 | 0.35 | 0.64 |
Low Estimate | 0.04 | 0.09 | 0.25 | 0.61 |
High Estimate | 0.14 | 0.22 | 0.41 | 0.68 |
Year Ago EPS | -0.07 | 0.02 | 0.05 | 0.35 |
Revenue Estimate | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 3 |
Avg. Estimate | 114.05M | 150.82M | 501.17M | 549.33M |
Low Estimate | 93.6M | 136.3M | 496.4M | 548.2M |
High Estimate | 122.5M | 160.6M | 506.7M | 550M |
Year Ago Sales | 123.81M | N/A | 464.8M | 501.17M |
Sales Growth (year/est) | -7.90% | N/A | 7.80% | 9.60% |
Earnings History | 2023-09-29 | 2023-12-30 | 2024-03-30 | 2024-06-29 |
---|---|---|---|---|
EPS Est. | 0.06 | 0.09 | 0.17 | 0.24 |
EPS Actual | -0.07 | 0.02 | 0.14 | -0.03 |
Difference | -0.13 | -0.07 | -0.03 | -0.27 |
Surprise % | -216.70% | -77.80% | -17.60% | -112.50% |
EPS Trend | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.09 | 0.16 | 0.35 | 0.64 |
7 Days Ago | 0.09 | 0.16 | 0.35 | 0.64 |
30 Days Ago | 0.09 | 0.16 | 0.35 | 0.64 |
60 Days Ago | 0.13 | 0.28 | 0.83 | 1.29 |
90 Days Ago | 0.13 | 0.28 | 0.81 | 1.29 |
EPS Revisions | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | N/A |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | BIOX | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current Qtr. | 228.60% | N/A | N/A | N/A |
Next Qtr. | 700.00% | N/A | N/A | N/A |
Current Year | 600.00% | N/A | N/A | N/A |
Next Year | 82.90% | N/A | N/A | N/A |
Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
Past 5 Years (per annum) | N/A | N/A | N/A | N/A |